InvestorLens

COLL — COLLEGIUM PHARMACEUTICAL INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying COLL?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
67
Institutional Conviction
Mixed · 2 buying vs 1 selling last quarter
49
Macro Tailwind
Macro conditions are mixed for this sector
57
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their COLL position last quarter, 2 bought and 1 sold (67% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen)
  • +3 tracked investors reported holding COLL at their latest filing
  • +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About COLLEGIUM PHARMACEUTICAL INC (COLL)

COLLEGIUM PHARMACEUTICAL INC (COLL) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $27M. Across recent filings, tracked investors recorded 6 new positions, 2 increased, 2 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in COLL

67
/100
Institutional Accumulation
Added / Increased8
Reduced2
Exited2
BearishBullish
Crowded Trade Score™

How many top investors track COLL

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

COLL Ownership Composition

How COLLEGIUM PHARMACEUTICAL INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
100% of tracked value
Institutions
3
tracked investors
Total Reported
$33.7M
combined 13F value
Types1
  • Multi-Strategy / Quant100.0%
Multi-Strategy / Quant(3)
100.0%

Tracked investors currently reporting COLL

1 tracked investor has since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    736.9K
    Value
    $26.7M
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    78.7K
    Value
    $2.8M
    % Portfolio
    0.00%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    114K
    Value
    $4.1M
    % Portfolio
    0.00%

Previously held COLL

These investors reported COLL in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Paul Tudor JonesTudor Investment Corp14K$461.5KMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold COLL?
3 tracked institutional investors disclosed a position in COLL (COLLEGIUM PHARMACEUTICAL INC) in their most recent 13F filing.
Who is the largest institutional holder of COLL?
Izzy Englander, Millennium Management, holds the largest disclosed position in COLL, valued at $27M.
Did institutional ownership of COLL increase or decrease?
Across recent 13F filings, tracked investors recorded 6 new positions, 2 increased, 2 reduced, and 2 fully exited COLL.
Where does this COLL ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.